Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B

Drygalski, Annette Von; Giermasz, Adam; Castaman, Giancarlo; Key, Nigel S.; Lattimore, Susan; Leebeek, Frank; Miesbach, Wolfgang; Recht, Michael; Long, Alison; Gut, Robert; Sawyer, Eileen K.; Pipe, Steven W.

doi:10.1182/bloodadvances.2019000811

Drygalski, A.V. (Annette Von), Giermasz, A. (Adam), G. Castaman (Giancarlo), Key, N.S. (Nigel S.), Lattimore, S. (Susan), F.W.G. Leebeek (Frank), Miesbach, W. (Wolfgang), Recht, M. (Michael), Long, A. (Alison), Gut, R. (Robert), et al. Pipe, S.W. (Steven W.)

2019-11-12

Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B

Blood Advances , Volume 3 - Issue 21 p. 3241- 3247

Additional Metadata
Persistent URL	doi.org/10.1182/bloodadvances.2019000811, hdl.handle.net/1765/121565
Journal	Blood Advances
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Drygalski, A.V. (Annette Von), Giermasz, A. (Adam), Castaman, G., Key, N.S. (Nigel S.), Lattimore, S. (Susan), Leebeek, F., … Pipe, S.W. (Steven W.). (2019). Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Advances, 3(21), 3241–3247. doi:10.1182/bloodadvances.2019000811

Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B

Publication

Publication

About

Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B

Publication

Publication

Workflow

Workflow

Add Content